Farmaindustria says sustainability, access and innovation should not be incompatible within the Spanish NHS

Antoni Esteve, president of the Spanish trade group Farmaindustria, during his speech at the XV Pharmaceutical Industry Meeting held at the Menéndez Pelayo University (UIMP) in Santander, stressed that “it is necessary to redirect the current debate around high prices of pharmaceutical innovations and their budgetary impact towards a more positive assessment on the benefits biomedical research brings to society through multiple ways, for health care, society and economy.”

This meeting, which is organized annually by the UIMP in collaboration with Madrid’s Carlos III University sponsored by Farmaindustria, has focused in one of the main debates in the current health care environment: financing innovations.

“Living in a new era of medicines”